Two Sigma Investments’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-97,327
| Closed | -$610K | – | 3394 |
|
|
2025
Q1 | $610K | Sell |
97,327
-388,463
| -80% | -$2.44M | ﹤0.01% | 2380 |
|
|
2024
Q4 | $3.94M | Buy |
485,790
+331,760
| +215% | +$2.69M | 0.01% | 1201 |
|
|
2024
Q3 | $2.78M | Sell |
154,030
-149,401
| -49% | -$2.7M | 0.01% | 1416 |
|
|
2024
Q2 | $3.13M | Sell |
303,431
-164,017
| -35% | -$1.69M | 0.01% | 1197 |
|
|
2024
Q1 | $4.96M | Buy |
467,448
+200,591
| +75% | +$2.13M | 0.01% | 929 |
|
|
2023
Q4 | $2.44M | Buy |
266,857
+182,794
| +217% | +$1.67M | 0.01% | 1318 |
|
|
2023
Q3 | $872K | Buy |
84,063
+42,563
| +103% | +$441K | ﹤0.01% | 1944 |
|
|
2023
Q2 | $594K | Buy |
41,500
+12,400
| +43% | +$178K | ﹤0.01% | 2180 |
|
|
2023
Q1 | $208K | Buy |
+29,100
| New | +$208K | ﹤0.01% | 2464 |
|
|
2022
Q3 | – | Sell |
-35,304
| Closed | -$298K | – | 2673 |
|
|
2022
Q2 | $298K | Sell |
35,304
-4,912
| -12% | -$41.5K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $547K | Sell |
40,216
-23,580
| -37% | -$321K | ﹤0.01% | 1938 |
|
|
2021
Q4 | $1.26M | Buy |
63,796
+41,241
| +183% | +$811K | ﹤0.01% | 1550 |
|
|
2021
Q3 | $724K | Sell |
22,555
-17,429
| -44% | -$559K | ﹤0.01% | 1853 |
|
|
2021
Q2 | $1.35M | Sell |
39,984
-14,671
| -27% | -$496K | ﹤0.01% | 1542 |
|
|
2021
Q1 | $2.05M | Buy |
+54,655
| New | +$2.05M | 0.01% | 1257 |
|